Meyka Pro banner
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERSNASDAQ
HealthcareMedical - Devices
$2.84
$0.13(4.80%)
U.S. Market opens in 2h 58m

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap572.3M
P/E Ratio-78.87
EPS (TTM)$-0.05
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$2.24
3 Months$3.04
1 Year Target$3.19

CERS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cerus Corporation (NASDAQ: CERS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cerus Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CERS on the NASDAQ shows an RSI of 55.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.19 for the NASDAQ listing.

Key metrics behind Cerus Corporation's NASDAQ-traded stock include a P/E ratio of -78.87 and a market capitalization of 572.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CERS on the NASDAQ.

Price Performance (NASDAQ: CERS)

1-Day Change
4.80%
5-Day Change
23.48%
1-Month Change
-8.09%
3-Month Change
9.23%
6-Month Change
26.79%
Year-to-Date (YTD) Change
37.86%
1-Year Change
113.53%
3-Year Change
47.15%
5-Year Change
-52.75%
All-Time (Max) Change
-76.58%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

2,750 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions